Details

Autor(en) / Beteiligte

• Seth, Rahul, MD
• Moss, Arthur J., MD
• McNitt, Scott, MS
• Zareba, Wojciech, MD, PhD
• Andrews, Mark L., BBA
• Qi, Ming, PhD
• Robinson, Jennifer L., MS
• Goldenberg, Ilan, MD
• Ackerman, Michael J., MD, PhD
• Benhorin, Jesaia, MD
• Kaufman, Elizabeth S., MD
• Locati, Emanuela H., MD, PhD
• Napolitano, Carlo, MD
• Priori, Silvia G., MD, PhD
• Schwartz, Peter J., MD
• Towbin, Jeffrey A., MD
• Vincent, G. Michael, MD
• Zhang, Li, MD

Titel

Long QT Syndrome and Pregnancy

Ist Teil von

• Journal of the American College of Cardiology, 2007-03, Vol.49 (10), p.1092-1098

Ort / Verlag

New York, NY: Elsevier Inc

Erscheinungsjahr

2007

Link zum Volltext

Quelle

Elsevier ScienceDirect Journals Complete

Beschreibungen/Notizen

• Long QT Syndrome and Pregnancy Rahul Seth, Arthur J. Moss, Scott McNitt, Wojciech Zareba, Mark L. Andrews, Ming Qi, Jennifer L. Robinson, Ilan Goldenberg, Michael J. Ackerman, Jesaia Benhorin, Elizabeth S. Kaufman, Emanuela H. Locati, Carlo Napolitano, Silvia G. Priori, Peter J. Schwartz, Jeffrey A. Towbin, G. Michael Vincent, Li Zhang The risk of experiencing an adverse cardiac event, including syncope, aborted cardiac arrest, and sudden death, during and after pregnancy was analyzed for women who had their first birth from 1980 to 2003 (n = 391). Compared with a time period before a woman’s first conception, the pregnancy time was associated with a reduced risk of cardiac events and an increased risk during the 9-month postpartum period, especially among women with the LQT2 genotype. Beta-blockers were associated with a reduction in cardiac events during the high-risk postpartum time period.